Accredo by Evernorth

In the latest Insights article, our Product Strategy leader shares her perspective on cell and gene therapies and why it’s no longer a “lightning strike” moment – it's a storm. What does the future hold for gene and cell therapies and specialty pharmacy? Read more: https://bit.ly/41L76yS #SpecialtyPharmacy #GeneTherapy #CellTherapy

We combine unparalleled access, personalized care and an unmatched delivery network. Discover how our Oncology Therapeutic Resource Center® is making a difference for patients; and how our powerful reach and resources are delivering successful launches for oncology therapy manufacturers: https://lnkd.in/gXdEntzC #OncologyTRC #SpecialtyPharmacy

MyAccredoPatients.com, the specialty prescriber portal that puts essential information at your fingertips. Stay on top of prescription status, track prior authorizations (PAs), manage shipments, and generate patient reports. Save time on admin tasks and focus on what matters most: your patients. Visit MyAccredoPatients.com to get started. #SpecialtyPharmacy

We recently sponsored the 17th Annual Face of Hope Breakfast hosted by the Little Red Door Cancer Agency. This event celebrates the strength and resilience of cancer patients and their families while raising critical funds to support those facing a cancer diagnosis. We’re committed to enhancing the lives of patients through personalized oncology care and innovative support programs, making this event especially meaningful. #SpecialtyPharmacy #LittleRedDoor

Accredo’s Oncology Therapeutic Resource Center® (TRC) goes beyond the prescription to provide comprehensive care for cancer patients. We offer personalized support programs and seamless therapy distribution, addressing social determinants of health (SDoH) by offering nutritional support and other vital resources to help improve overall patient well-being. Learn more in our latest white paper: https://bit.ly/48X0teu #OncologyTRC #TherapeuticResourceCenter #SpecialtyPharmacy

We’re excited to announce that Accredo specialty pharmacy successfully delivered the first shipment and treatment of ZOLGENSMA in Hawaii! Although ZOLGENSMA has been available since 2019, this marks the first time it has been administered in Hawaii, following the inclusion of spinal muscular atrophy (SMA) in newborn screenings across all 50 states as of January 1, 2024. This milestone brings new hope to families affected by SMA, and we’re proud to play a role in ensuring timely access to this life-changing therapy. Read the full story here: https://bit.ly/3YV7ibR #SpecialtyPharmacy #TherapeuticResourceCenter #TRC #SMA #SpinalMuscularAtrophy

We combine individualized support from our Oncology Therapeutic Resource Center with the power of our infrastructure to help manufacturers in ways smaller pharmacies can’t. Dive into the details in our latest whitepaper: https://bit.ly/48X0teu #OncologyTRC #SpecialtyPharmacy

November is Pulmonary Arterial Hypertension Awareness Month, and at Accredo, we’re dedicated to supporting patients living with this serious and often difficult to diagnose condition. Pulmonary arterial hypertension (PAH) affects the arteries in the lungs and heart, making early detection and treatment essential. Through our specialized Pulmonary Arterial Hypertension TRC, we provide personalized care, helping patients access vital therapies and navigate their treatment plans with expert guidance. Join us this month in raising awareness about PAH and the importance of early detection and treatment for better patient outcomes. https://lnkd.in/ez9W5uXE #PAH #SpecialtyPharmacy #PulmonaryArterialHypertension

November is Alpha-1 Awareness Month, and this year’s theme is “The Power to Connect”. We recognize the importance of building connections – whether it’s with patients and caregivers or providing access to vital therapies for those with Alpha-1 antitrypsin deficiency. Our APC and ICC Therapeutic Resource Centers® are proud to stand with the Alpha-1 community, providing specialized care for Alpha-1 patients. Learn more about how we support Alpha-1 patients: https://bit.ly/3NIkHPr #Alpha1AwarenessMonth #SpecialtyPharmacy Alpha-1 Foundation

Accredo's latest research highlights the power of combining our Therapeutic Resource Center (TRC) model with motivational interviewing to improve medication adherence. In a study of 41,000 patients across 300 disease states, patients receiving this layered approach showed an impressive 18% increase in adherence compared to controls. This demonstrates how personalized specialty pharmacy care and expert support can lead to better outcomes for patients managing complex conditions. Read the full article to learn more about these exciting findings: https://bit.ly/3NLqMdY #SpecialtyPharmacy #TRC #TherapeuticResourceCenter